These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10666408)

  • 1. Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes.
    Napoleone E; Di Santo A; Camera M; Tremoli E; Lorenzet R
    Circ Res; 2000 Feb; 86(2):139-43. PubMed ID: 10666408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes.
    He M; He X; Xie Q; Chen F; He S
    Thromb Res; 2006; 117(5):579-90. PubMed ID: 15953627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of angiotensin II on tissue factor expression in human peripheral blood monocytes and its mechanisms].
    He MX; He XF; Xie QZ; Chen FP; He SL
    Zhonghua Xue Ye Xue Za Zhi; 2003 Sep; 24(9):470-3. PubMed ID: 14575590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of blockade of the renin-angiotensin system on tissue factor and plasminogen activator inhibitor-1 synthesis in human cultured monocytes.
    Nagata K; Ishibashi T; Sakamoto T; Nakazato K; Seino Y; Yokoyama K; Ohkawara H; Teramoto T; Maruyama Y
    J Hypertens; 2001 Apr; 19(4):775-83. PubMed ID: 11330881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the renin-angiotensin system downregulates tissue factor and vascular endothelial growth factor in human breast carcinoma cells.
    Napoleone E; Cutrone A; Cugino D; Amore C; Di Santo A; Iacoviello L; de Gaetano G; Donati MB; Lorenzet R
    Thromb Res; 2012 Jun; 129(6):736-42. PubMed ID: 22188725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.
    Müller DN; Mervaala EM; Dechend R; Fiebeler A; Park JK; Schmidt F; Theuer J; Breu V; Mackman N; Luther T; Schneider W; Gulba D; Ganten D; Haller H; Luft FC
    Am J Pathol; 2000 Jul; 157(1):111-22. PubMed ID: 10880382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
    Schmeisser A; Soehnlein O; Illmer T; Lorenz HM; Eskafi S; Roerick O; Gabler C; Strasser R; Daniel WG; Garlichs CD
    Biochem Biophys Res Commun; 2004 Dec; 325(2):532-40. PubMed ID: 15530425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis.
    Keidar S; Attias J; Heinrich R; Coleman R; Aviram M
    Atherosclerosis; 1999 Oct; 146(2):249-57. PubMed ID: 10532681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Captopril-impaired production of tumor necrosis factor-alpha-induced interleukin-1beta in human monocytes is associated with altered intracellular distribution of nuclear factor-kappaB.
    Andersson P; Cederholm T; Johansson AS; Palmblad J
    J Lab Clin Med; 2002 Aug; 140(2):103-9. PubMed ID: 12228766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation.
    Napoleone E; di Santo A; Peri G; Mantovani A; de Gaetano G; Donati MB; Lorenzet R
    J Leukoc Biol; 2004 Jul; 76(1):203-9. PubMed ID: 15226367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possible link between obesity and cardiovascular risk?
    Napoleone E; DI Santo A; Amore C; Baccante G; di Febbo C; Porreca E; de Gaetano G; Donati MB; Lorenzet R
    J Thromb Haemost; 2007 Jul; 5(7):1462-8. PubMed ID: 17425664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
    Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
    Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Antihypertensive Therapies That Increase Expression of Cardioprotective Biomarkers Associated With the Renin-Angiotensin and Kallikrein-Kinin Systems.
    Lezama-Martinez D; Flores-Monroy J; Fonseca-Coronado S; Hernandez-Campos ME; Valencia-Hernandez I; Martinez-Aguilar L
    J Cardiovasc Pharmacol; 2018 Dec; 72(6):291-295. PubMed ID: 30422889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin A inhibits monocyte tissue factor activation in cardiac transplant recipients.
    Hölschermann H; Kohl O; Maus U; Dürfeld F; Bierhaus A; Nawroth PP; Lohmeyer J; Tillmanns H; Haberbosch W
    Circulation; 1997 Dec; 96(12):4232-8. PubMed ID: 9416887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm.
    Raghavendra V; Chopra K; Kulkarni SK
    Neuropeptides; 2001 Feb; 35(1):65-9. PubMed ID: 11346312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II, tissue factor and the thrombotic paradox of hypertension.
    Celi A; Cianchetti S; Dell'Omo G; Pedrinelli R
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1723-9. PubMed ID: 21108554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation.
    Napoleone E; Di Santo A; Bastone A; Peri G; Mantovani A; de Gaetano G; Donati MB; Lorenzet R
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):782-7. PubMed ID: 12006390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lipopolysaccharide-induced tissue factor expression in monocytes by urinary trypsin inhibitor in vitro and in vivo.
    Molor-Erdene P; Okajima K; Isobe H; Uchiba M; Harada N; Shimozawa N; Okabe H
    Thromb Haemost; 2005 Jul; 94(1):136-45. PubMed ID: 16113797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.